Spots Global Cancer Trial Database for Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Official Title: An Open-Label Multicenter 3-Arm Randomized Phase 2 Study to Assess the Efficacy and Safety of TTX-030 and Chemotherapy With or Without Budigalimab, Compared to Chemotherapy Alone, for the Treatment of Patients Not Previously Treated for Metastatic Pancreatic Adenocarcinoma
Study ID: NCT06119217
Conditions
Study Description
Brief Summary: This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with chemotherapy (gemcitabine + nab-paclitaxel) in subjects with metastatic PDAC who did not have prior treatment for metastatic disease and are eligible to receive gemcitabine and nab-paclitaxel chemotherapy as SOC.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Investigative Site, Tucson, Arizona, United States
Investigative SIte, Hot Springs, Arkansas, United States
Investigative Site, Los Angeles, California, United States
Investigative Site, Denver, Colorado, United States
Investigative Site, Saint Petersburg, Florida, United States
Investigative Site, Tallahassee, Florida, United States
Investigative Site, West Palm Beach, Florida, United States
Investigative Site, Atlanta, Georgia, United States
Investigative Site, Columbia, Maryland, United States
Investigative Site, Florham Park, New Jersey, United States
Investigative Site, Asheville, North Carolina, United States
Investigative Site, Columbus, Ohio, United States
Investigative Site, Horsham, Pennsylvania, United States
Investigative Site, Dallas, Texas, United States
Investigative Site, San Antonio, Texas, United States
Investigative Site, Tyler, Texas, United States
Investigative Site, Arlington, Virginia, United States
Investigative Site, Norfolk, Virginia, United States
Investigative Site, Roanoke, Virginia, United States
Investigative Site, Goyang-si, , Korea, Republic of
Investigative Site, Seongam, , Korea, Republic of
Investigative Site, Seoul, , Korea, Republic of
Investigative Site, Seoul, , Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
